Lyn physically associates with the erythropoietin receptor and may play a role in activation of the Stat5 pathway.

Abstract:

:Protein tyrosine phosphorylation plays a crucial role in signaling from the receptor for erythropoietin (Epo), although the Epo receptor (EpoR) lacks the tyrosine kinase domain. We have previously shown that the Jak2 tyrosine kinase couples with the EpoR to transduce a growth signal. In the present study, we demonstrate that Lyn, a Src family tyrosine kinase, physically associates with the EpoR in Epo-dependent hematopoietic cell lines, 32D/EpoR-Wt and F36E. Coexpression experiments in COS7 cells further showed that Lyn induces tyrosine phosphorylation of the EpoR and that both LynA and LynB, alternatively spliced forms of Lyn, bind with the membrane-proximal 91-amino acid region of the EpoR cytoplasmic domain. In vitro binding studies using GST-Lyn fusion proteins further showed that the Src homology (SH)-2 domain of Lyn specifically binds with the tyrosine-phosphorylated EpoR in lysate from Epo-stimulated cells, whereas the tyrosine kinase domain of Lyn binds with the unphosphorylated EpoR. Far-Western blotting and synthetic phosphopeptide competition assays further indicated that the Lyn SH2 domain directly binds to the tyrosine-phosphorylated EpoR, most likely through its interaction with phosphorylated Y-464 or Y-479 in the carboxy-terminal region of the EpoR. In vitro binding studies also demonstrated that the Lyn SH2 domain directly binds to tyrosine-phosphorylated Jak2. In vitro reconstitution experiments in COS7 cells further showed that Lyn induces tyrosine phosphorylation of Stat5, mainly on Y-694, and activates the DNA-binding and transcription-activating abilities of Stat5. In agreement with this, Lyn enhanced the Stat5-dependent transcriptional activation when overexpressed in 32D/EpoR-Wt cells. In addition, Lyn was demonstrated to phosphorylate the EpoR and Stat5 on tyrosines in vitro. These results suggest that Lyn may play a role in activation of the Jak2/Stat5 and other signaling pathways by the EpoR.

journal_name

Blood

journal_title

Blood

authors

Chin H,Arai A,Wakao H,Kamiyama R,Miyasaka N,Miura O

subject

Has Abstract

pub_date

1998-05-15 00:00:00

pages

3734-45

issue

10

eissn

0006-4971

issn

1528-0020

journal_volume

91

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis.

    abstract::The zinc finger transcription factor GATA-2 is highly expressed in immature hematopoietic cells and declines with blood cell maturation. To investigate its role in normal adult hematopoiesis, a bicistronic retroviral vector encoding GATA-2 and the green fluorescent protein (GFP) was used to maintain the high levels of...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Persons DA,Allay JA,Allay ER,Ashmun RA,Orlic D,Jane SM,Cunningham JM,Nienhuis AW

    更新日期:1999-01-15 00:00:00

  • Cyclophosphamide, fludarabine, alemtuzumab, and rituximab as salvage therapy for heavily pretreated patients with chronic lymphocytic leukemia.

    abstract::Patients with relapsed chronic lymphocytic leukemia (CLL) and high-risk features, such as fludarabine refractoriness, complex karyotype, or abnormalities of chromosome 17p, experience poor outcomes after standard fludaradine-based regimens. Alemtuzumab is a chimeric CD52 monoclonal antibody with activity in CLL patien...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-03-341032

    authors: Badoux XC,Keating MJ,Wang X,O'Brien SM,Ferrajoli A,Faderl S,Burger J,Koller C,Lerner S,Kantarjian H,Wierda WG

    更新日期:2011-08-25 00:00:00

  • Regulation of early human hematopoietic (BFU-E and CFU-GEMM) progenitor cells in vitro by interleukin 1-induced fibroblast-conditioned medium.

    abstract::Stimulators of human erythroid burst-forming units (BFU-E) and multipotential colony-forming cells (CFU-GEMM) can be produced by a number of different cell types. A product of human peripheral blood monocytes, interleukin 1 (IL-1), was evaluated for its ability to stimulate fibroblast cultures to produce stimulators o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zucali JR,Broxmeyer HE,Dinarello CA,Gross MA,Weiner RS

    更新日期:1987-01-01 00:00:00

  • Regulation of fibrinolysis by platelet-released plasminogen activator inhibitor 1: light scattering and ultrastructural examination of lysis of a model platelet-fibrin thrombus.

    abstract::We have investigated the role of plasminogen activator inhibitor 1 (PAI-1) in the regulation of fibrinolysis using a model thrombus composed of thrombin-stimulated platelets, fibrin(ogen), plasminogen, and recombinant tissue-type plasminogen activator. Laser light scattering kinetic measurements showed that clot lysis...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Braaten JV,Handt S,Jerome WG,Kirkpatrick J,Lewis JC,Hantgan RR

    更新日期:1993-03-01 00:00:00

  • Nucleolar localization of RPS19 protein in normal cells and mislocalization due to mutations in the nucleolar localization signals in 2 Diamond-Blackfan anemia patients: potential insights into pathophysiology.

    abstract::Ribosomal protein S19 (RPS19) is frequently mutated in Diamond-Blackfan anemia (DBA), a rare congenital hypoplastic anemia. Recent studies have shown that RPS19 expression decreases during terminal erythroid differentiation. Currently no information is available on the subcellular localization of normal RPS19 and the ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-12-3878

    authors: Da Costa L,Tchernia G,Gascard P,Lo A,Meerpohl J,Niemeyer C,Chasis JA,Fixler J,Mohandas N

    更新日期:2003-06-15 00:00:00

  • A new adenoviral helper-dependent vector results in long-term therapeutic levels of human coagulation factor IX at low doses in vivo.

    abstract::We have developed a new helper-dependent (HD) adenoviral vector FTC that contains 3 cis-acting sequences as stuffer DNA: a human fragment of alphoid repeat DNA, matrix-attachment regions (MARs), and the hepatocyte control region enhancer. To determine the most robust human coagulation factor IX (hFIX) expression casse...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v99.11.3923

    authors: Ehrhardt A,Kay MA

    更新日期:2002-06-01 00:00:00

  • Acquired granular pool defect in stored platelets.

    abstract::Platelets stored as concentrates (PC) for 72 h at 22 degrees C develop a functional defect. Alterations in adenine nucleotides of platelets have been shown to affect platelet function. Adenine nucleotide content of platelets was measured before and after storage and a decrease of 27.1 /+- 1.7% (mean /+- SE) in ATP and...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rao AK,Niewiarowski S,Murphy S

    更新日期:1981-02-01 00:00:00

  • Recurrent CDKN1B (p27) mutations in hairy cell leukemia.

    abstract::Hairy cell leukemia (HCL) is marked by near 100% mutational frequency of BRAFV600E mutations. Recurrent cooperating genetic events that may contribute to HCL pathogenesis or affect the clinical course of HCL are currently not described. Therefore, we performed whole exome sequencing to explore the mutational landscape...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-04-643361

    authors: Dietrich S,Hüllein J,Lee SC,Hutter B,Gonzalez D,Jayne S,Dyer MJ,Oleś M,Else M,Liu X,Słabicki M,Wu B,Troussard X,Dürig J,Andrulis M,Dearden C,von Kalle C,Granzow M,Jauch A,Fröhling S,Huber W,Meggendorfer M,Hafe

    更新日期:2015-08-20 00:00:00

  • Immunomodulatory effects of lenalidomide and pomalidomide on interaction of tumor and bone marrow accessory cells in multiple myeloma.

    abstract::The bone marrow (BM) microenvironment consists of extracellular-matrix and the cellular compartment including immune cells. Multiple myeloma (MM) cell and BM accessory cell interaction promotes MM survival via both cell-cell contact and cytokines. Immunomodulatory agents (IMiDs) target not only MM cells, but also MM c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-04-279893

    authors: Görgün G,Calabrese E,Soydan E,Hideshima T,Perrone G,Bandi M,Cirstea D,Santo L,Hu Y,Tai YT,Nahar S,Mimura N,Fabre C,Raje N,Munshi N,Richardson P,Anderson KC

    更新日期:2010-10-28 00:00:00

  • Normal iron absorption and decreased red cell iron uptake in the aged.

    abstract::Absorption of iron was studied with a double-isotope technique that allowed differentiation between "mucosal uptake," "mucosal transfer," and ultimate "retention" of iron. A physiologic dose of ferrous sulfate was administered to 25 healthy young adults, 40 active aged persons, and 20 patients with uncomplicated iron ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Marx JJ

    更新日期:1979-02-01 00:00:00

  • The C-class chemokine lymphotactin costimulates the apoptosis of human CD4(+) T cells.

    abstract::Clonal expansion of activated T cells is controlled by homeostatic mechanisms leading to cell death of a large proportion of the cells. The CD3/TcR pathway induces cell death, mostly when triggered in the absence of costimulatory signal. The unique T cell-specific chemokine of the C class, lymphotactin (Lptn), has rec...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.8.2205

    authors: Cerdan C,Devilard E,Xerri L,Olive D

    更新日期:2001-04-15 00:00:00

  • TNM classification system for primary cutaneous lymphomas other than mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the Cutaneous Lymphoma Task Force of the European Organization of Resear

    abstract::Currently availabel staging systems for non-Hodgkin lymphomas are not useful for clinical staging classification of most primary cutaneous lymphomas. The tumor, node, metastases (TNM) system used for mycosis fungoides (MF) and Sézary syndrome (SS) is not appropriate for other primary cutaneous lymphomas. A usable, uni...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-10-054601

    authors: Kim YH,Willemze R,Pimpinelli N,Whittaker S,Olsen EA,Ranki A,Dummer R,Hoppe RT,ISCL and the EORTC.

    更新日期:2007-07-15 00:00:00

  • Oligodeoxynucleotide-mediated inhibition of c-myb gene expression in autografted bone marrow: a pilot study.

    abstract::Antisense oligodeoxynucleotide (ODN) drugs might be more effective if their delivery was optimized and they were targeted to short-lived proteins encoded by messenger RNA (mRNA) species with equally short half-lives. To test this hypothesis, an ODN targeted to the c-myb proto-oncogene was developed and used to purge m...

    journal_title:Blood

    pub_type: 临床试验,杂志文章

    doi:10.1182/blood.v99.4.1150

    authors: Luger SM,O'Brien SG,Ratajczak J,Ratajczak MZ,Mick R,Stadtmauer EA,Nowell PC,Goldman JM,Gewirtz AM

    更新日期:2002-02-15 00:00:00

  • Phase 2 study of panobinostat with or without rituximab in relapsed diffuse large B-cell lymphoma.

    abstract::The majority of diffuse large B-cell lymphoma (DLBCL) tumors contain mutations in histone-modifying enzymes (HMEs), indicating a potential therapeutic benefit of histone deacetylase inhibitors (HDIs), and preclinical data suggest that HDIs augment the effect of rituximab. In this randomized phase 2 study, we evaluated...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2016-02-699520

    authors: Assouline SE,Nielsen TH,Yu S,Alcaide M,Chong L,MacDonald D,Tosikyan A,Kukreti V,Kezouh A,Petrogiannis-Haliotis T,Albuquerque M,Fornika D,Alamouti S,Froment R,Greenwood CM,Oros KK,Camglioglu E,Sharma A,Christodoulopoul

    更新日期:2016-07-14 00:00:00

  • Excellent outcomes following hematopoietic cell transplantation for Wiskott-Aldrich syndrome: a PIDTC report.

    abstract::Wiskott-Aldrich syndrome (WAS) is an X-linked disease caused by mutations in the WAS gene, leading to thrombocytopenia, eczema, recurrent infections, autoimmune disease, and malignancy. Hematopoietic cell transplantation (HCT) is the primary curative approach, with the goal of correcting the underlying immunodeficienc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019002939

    authors: Burroughs LM,Petrovic A,Brazauskas R,Liu X,Griffith LM,Ochs HD,Bleesing JJ,Edwards S,Dvorak CC,Chaudhury S,Prockop SE,Quinones R,Goldman FD,Quigg TC,Chandrakasan S,Smith AR,Parikh S,Dávila Saldaña BJ,Thakar MS,Phela

    更新日期:2020-06-04 00:00:00

  • Cytogenetic features of Hodgkin's disease suggest possible origin from a lymphocyte.

    abstract::Surface marker and gene rearrangement data have supported various hypotheses about the origin of the malignant cell in Hodgkin's disease. Cytogenetic data about this disorder, however, are very scanty. To determine if any chromosomal abnormalities that could add further information to this controversial point are pres...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cabanillas F,Pathak S,Trujillo J,Grant G,Cork A,Hagemeister FB,Velasquez WS,McLaughlin P,Redman J,Katz R

    更新日期:1988-06-01 00:00:00

  • The BXH2 mutation in IRF8 differentially impairs dendritic cell subset development in the mouse.

    abstract::Among dendritic cell (DC) subsets, CD8alpha(+) DCs and plasmacytoid DCs (pDCs) produce high levels of IL12 and type I interferons (IFNs), respectively, and confer early innate immunity. Development of CD8alpha(+) DCs and pDCs requires the interferon regulatory factor 8 (IRF8). Recently, a spontaneous point mutation wa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-07-100750

    authors: Tailor P,Tamura T,Morse HC 3rd,Ozato K

    更新日期:2008-02-15 00:00:00

  • Use of a generally applicable tissue factor--dependent factor V assay to detect activated protein C-resistant factor Va in patients receiving warfarin and in patients with a lupus anticoagulant.

    abstract::The original activated partial thromboplastin time-based assay for activated protein C (APC)-resistant factor Va (FVa) requires carefully prepared fresh plasma and cannot be used in patients receiving warfarin or in patients with antiphospholipid antibodies. A new test is described here that circumvents these limitati...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Le DT,Griffin JH,Greengard JS,Mujumdar V,Rapaport SI

    更新日期:1995-04-01 00:00:00

  • Selection of patients for bone marrow transplantation in severe aplastic anemia.

    abstract::Despite androgens and intensive supportive care, satisfactory survival in severe aplastic anemia remains at 20% or less. Histocompatible bone marrow transplantation can restore normal hematopoiesis in approximately 40% of similarly severe individuals. Delay of transplantation for 3 wk after diagnosis allows time for p...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Camitta BM,Rappeport JM,Parkman R,Nathan DG

    更新日期:1975-03-01 00:00:00

  • Disease characteristics and clinical outcome in young adults with essential thrombocythemia versus early/prefibrotic primary myelofibrosis.

    abstract::In the present study, we investigated disease characteristics and clinical outcome in young patients (< 40 years) with World Health Organization (WHO)-defined essential thrombocythemia (ET) compared with early/prefibrotic primary myelofibrosis (PMF) with presenting thrombocythemia. We recruited 213 young patients (med...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-01-407981

    authors: Barbui T,Thiele J,Carobbio A,Passamonti F,Rumi E,Randi ML,Bertozzi I,Vannucchi AM,Gisslinger H,Gisslinger B,Finazzi G,Ruggeri M,Rodeghiero F,Rambaldi A,Gangat N,Tefferi A

    更新日期:2012-07-19 00:00:00

  • Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.

    abstract::We analyzed the incidence of posttransplant chronic myelogenous leukemia (CML) relapse in 283 consecutive related-donor (n = 177) and unrelated-donor (n = 106) allogeneic transplant recipients. Twenty-two of 165 related-donor recipients with stable or advanced disease at the time of transplant had hematologic relapse ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Enright H,Davies SM,DeFor T,Shu X,Weisdorf D,Miller W,Ramsay NK,Arthur D,Verfaillie C,Miller J,Kersey J,McGlave P

    更新日期:1996-07-15 00:00:00

  • Preferential nuclear accumulation of JAK2V617F in CD34+ but not in granulocytic, megakaryocytic, or erythroid cells of patients with Philadelphia-negative myeloproliferative neoplasia.

    abstract::Recently, Dawson et al identified a previously unrecognized nuclear role of JAK2 in the phosphorylation of histone H3 in hematopoietic cell lines. We searched nuclear JAK2 in total bone marrow (BM) cells and in 4 sorted BM cell populations (CD34(+), CD15(+), CD41(+), and CD71(+)) of 10 myeloproliferative neoplasia (MP...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2010-08-302265

    authors: Rinaldi CR,Rinaldi P,Alagia A,Gemei M,Esposito N,Formiggini F,Martinelli V,Senyuk V,Nucifora G,Pane F

    更新日期:2010-12-23 00:00:00

  • Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels.

    abstract::Congenital deficiency in coagulation factor XIII is a rare autosomal recessive bleeding disorder. Although the defect was characterized over 30 years ago, little is known about the molecular basis of the disorder. Here, we show two novel point mutations in the gene of the A-subunit of factor XIII in the genetically is...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Mikkola H,Syrjälä M,Rasi V,Vahtera E,Hämäläinen E,Peltonen L,Palotie A

    更新日期:1994-07-15 00:00:00

  • Mutual inhibition of murine erythropoiesis and granulopoiesis during combined erythropoietin, granulocyte colony-stimulating factor, and stem cell factor administration: in vivo interactions and dose-response surfaces.

    abstract::We investigated the in vivo effects of erythropoietin (EPO) on granulopoiesis and, conversely, the effect of granulocyte colony-stimulating factor (G-CSF) treatment on erythropoiesis. Recombinant human EPO at four different doses in combination with recombinant human G-CSF also at four different doses was simultaneous...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: de Haan G,Engel C,Dontje B,Nijhof W,Loeffler M

    更新日期:1994-12-15 00:00:00

  • Suppression of mouse myelopoiesis by administration of human lactoferrin in vivo and the comparative action of human transferrin.

    abstract::Purified human lactoferrin was assessed for its influence in vivo in untreated mice and in mice undergoing rebound myelopoiesis after sublethal dosages of Cytoxan. Fully iron-saturated lactoferrin suppressed the numbers of granulocytes and monocytes per femur, the numbers of granulocyte-macrophage progenitor cells (CF...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gentile P,Broxmeyer HE

    更新日期:1983-05-01 00:00:00

  • Re-establishment of VWF-dependent Weibel-Palade bodies in VWD endothelial cells.

    abstract::Type 3 von Willebrand disease (VWD) is a severe hemorrhagic defect in humans. We now identify the homozygous mutation in the Chapel Hill strain of canine type 3 VWD that results in premature termination of von Willebrand factor (VWF) protein synthesis. We cultured endothelium from VWD and normal dogs to study intracel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2004-02-0464

    authors: Haberichter SL,Merricks EP,Fahs SA,Christopherson PA,Nichols TC,Montgomery RR

    更新日期:2005-01-01 00:00:00

  • P-selectin binds to the D'-D3 domains of von Willebrand factor in Weibel-Palade bodies.

    abstract::It has recently been shown that the ultralarge platelet-recruiting von Willebrand factor (VWF) strings formed immediately at exocytosis from endothelial cells may be anchored to the cell surface by interaction with the integral membrane protein P-selectin. This finding of a new binding partner for VWF immediately prom...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-09-3635

    authors: Michaux G,Pullen TJ,Haberichter SL,Cutler DF

    更新日期:2006-05-15 00:00:00

  • Daratumumab, lenalidomide, bortezomib, and dexamethasone for transplant-eligible newly diagnosed multiple myeloma: the GRIFFIN trial.

    abstract::Lenalidomide, bortezomib, and dexamethasone (RVd) followed by autologous stem cell transplantation (ASCT) is standard frontline therapy for transplant-eligible patients with newly diagnosed multiple myeloma (NDMM). The addition of daratumumab (D) to RVd (D-RVd) in transplant-eligible NDMM patients was evaluated. Patie...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2020005288

    authors: Voorhees PM,Kaufman JL,Laubach J,Sborov DW,Reeves B,Rodriguez C,Chari A,Silbermann R,Costa LJ,Anderson LD Jr,Nathwani N,Shah N,Efebera YA,Holstein SA,Costello C,Jakubowiak A,Wildes TM,Orlowski RZ,Shain KH,Cowan AJ,

    更新日期:2020-08-20 00:00:00

  • Complete eradication of human B-cell lymphoma xenografts using rituximab in combination with the immunocytokine L19-IL2.

    abstract::The antibody-mediated delivery of therapeutic agents to sites of angiogenesis is an attractive strategy for anticancer therapy, but is largely unexplored in hematologic malignancies. In the present study, we show that the extra domain B (EDB) of fibronectin, a marker of angiogenesis, is expressed in B-cell non-Hodgkin...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-05-160747

    authors: Schliemann C,Palumbo A,Zuberbühler K,Villa A,Kaspar M,Trachsel E,Klapper W,Menssen HD,Neri D

    更新日期:2009-03-05 00:00:00

  • Persistent epstein-barr virus infection mimicking juvenile chronic myelogenous leukemia: immunologic and hematologic studies.

    abstract::Epstein-Barr virus (EBV) infections may induce a diverse clinical picture, ranging from the well characterized infectious mononucleosis (IM) syndrome to the rare X-linked lymphoproliferative syndrome. We describe two unrelated children, a 21-mo-old white boy and a 15-mo-old black girl, who presented with the clinical ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Herrod HG,Dow LW,Sullivan JL

    更新日期:1983-06-01 00:00:00